Hamilton, Scott

MDMA-assisted therapy for severe PTSD: a randomized, double-blind, placebo-controlled phase 3 study

Mitchell, J. M., Bogenschutz, M., Lilienstein, A., Harrison, C., Kleiman, S., Parker-Guilbert, K., Ot’alora G., M., Garas, W., Paleos, C., Gorman, I., et al. (2021) · Nature Medicine

Psychedelics and Drug StudiesPosttraumatic Stress Disorder Research

Cited by 1,004

MDMA-assisted therapy for moderate to severe PTSD: A randomized, placebo-controlled phase 3 trial

Mitchell, J. M., Ot’alora G., M., van der Kolk, B., Shannon, S., Bogenschutz, M., Gelfand, Y., Paleos, C., Nicholas, C. R., Quevedo, S., Balliett, B., et al. (2023) · Nature Medicine

Psychedelics and Drug StudiesPosttraumatic Stress Disorder Research

Cited by 455

3,4-methylenedioxymethamphetamine (MDMA)-assisted psychotherapy for post-traumatic stress disorder in military veterans, firefighters, and police officers: a randomised, double-blind, dose-response, phase 2 clinical trial

Mithoefer, M. C., Mithoefer, A. T., Feduccia, A. A., Jerome, L., Wagner, M., Wymer, J., Holland, J., Hamilton, S., Yazar-Klosinski, B., Emerson, A., et al. (2018) · The Lancet Psychiatry

Psychedelics and Drug StudiesPosttraumatic Stress Disorder Research

Cited by 439

Collateral Effect of Covid-19 on Stroke Evaluation in the United States

Kansagra, A. P., Goyal, M. S., Hamilton, S., & Albers, G. W. (2020) · New England Journal of Medicine

COVID-19 and healthcare impactsAcute Ischemic Stroke Management

Cited by 432

RETRACTED ARTICLE: MDMA-assisted psychotherapy for treatment of PTSD: study design and rationale for phase 3 trials based on pooled analysis of six phase 2 randomized controlled trials

Mithoefer, M. C., Feduccia, A. A., Jerome, L., Mithoefer, A., Wagner, M., Walsh, Z., Hamilton, S., Yazar-Klosinski, B., Emerson, A., & Doblin, R. (2019) · Psychopharmacology

Psychedelics and Drug StudiesPosttraumatic Stress Disorder Research

Cited by 359

Transplanted Stem Cell-Secreted Vascular Endothelial Growth Factor Effects Poststroke Recovery, Inflammation, and Vascular Repair

Horie, N., Pereira, M. P., Niizuma, K., Sun, G., Keren-Gill, H., Encarnacion, A., Shamloo, M., Hamilton, S. A., Jiang, K., Huhn, S., et al. (2011) · Stem Cells

Mesenchymal stem cell researchAngiogenesis and VEGF in Cancer

Cited by 240

MDMA-assisted psychotherapy for treatment of anxiety and other psychological distress related to life-threatening illnesses: a randomized pilot study

Wolfson, P. E., Andries, J., Feduccia, A. A., Jerome, L., Wang, J. B., Williams, E., Carlin, S. C., Sola, E., Hamilton, S., Yazar-Klosinski, B., et al. (2020) · Scientific Reports

Psychedelics and Drug StudiesMusic Therapy and Health

Cited by 169

RETRACTED ARTICLE: Long-term follow-up outcomes of MDMA-assisted psychotherapy for treatment of PTSD: a longitudinal pooled analysis of six phase 2 trials

Jerome, L., Feduccia, A. A., Wang, J. B., Hamilton, S., Yazar-Klosinski, B., Emerson, A., Mithoefer, M. C., & Doblin, R. (2020) · Psychopharmacology

Psychedelics and Drug StudiesPosttraumatic Stress Disorder Research

Cited by 159

MDMA-Assisted Therapy for Severe PTSD: A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study

Mitchell, J. M., Bogenschutz, M., Lilienstein, A., Harrison, C., Kleiman, S., Parker-Guilbert, K., Ot’alora G, M., Garas, W., Paleos, C., Gorman, I., et al. (2023) · Focus

Psychedelics and Drug StudiesPosttraumatic Stress Disorder Research

Cited by 93

Posttraumatic Growth After MDMA‐Assisted Psychotherapy for Posttraumatic Stress Disorder

Gorman, I., Belser, A. B., Jerome, L., Hennigan, C., Shechet, B., Hamilton, S., Yazar‐Klosinski, B., Emerson, A., & Feduccia, A. A. (2020) · Journal of Traumatic Stress

Psychedelics and Drug StudiesPosttraumatic Stress Disorder Research

Cited by 44

A Dedicated Spanish Language Line Increases Enrollment of Hispanics Into Prehospital Clinical Research

Sanossian, N., Rosenberg, L., Liebeskind, D. S., Starkman, S., Eckstein, M., Stratton, S., Pratt, F. D., Hamilton, S., Kim-Tenser, M., Sharma, L. K., et al. (2017) · Stroke

Ethics in Clinical ResearchInterpreting and Communication in Healthcare

Cited by 21

Modified Rankin Scale Disability Status at Day 4 Poststroke is an Informative Predictor of Long-Term Day 90 Outcome

Taleb, S., Lee, J. J.-H., Asanad, S., Starkman, S., Hamilton, S., Conwit, R. A., Sanossian, N., & Saver, J. L. (2023) · Journal of Stroke and Cerebrovascular Diseases

Acute Ischemic Stroke ManagementStroke Rehabilitation and Recovery

Cited by 3

Modified Rankin Scale disability status at day 4 poststroke is an informative predictor of long-term day 90 outcome

Taleb, S., Ji-hyun Lee, J., Asanad, S., Starkman, S., Hamilton, S., Gornbein, J., Conwit, R. A., Sanossian, N., & Saver, J. L. (2024) · Journal of Stroke and Cerebrovascular Diseases

Acute Ischemic Stroke ManagementStroke Rehabilitation and Recovery

Cited by 3